| Descriptor English: | Glycated Serum Proteins | ||||||
| Descriptor Spanish: |
Proteínas Séricas Glicadas
| ||||||
| Descriptor Portuguese: | Proteínas Séricas Glicadas | ||||||
| Descriptor French: | Protéine glycosylée sérique | ||||||
| Entry term(s): |
Blood Protein, Glycated Blood Protein, Glycosylated Blood Proteins, Glycated Blood Proteins, Glycosylated Glycated Blood Protein Glycated Blood Proteins Glycated Serum Protein Glycosylated Blood Protein Glycosylated Blood Proteins Glycosylated Serum Protein Glycosylated Serum Proteins Protein, Glycated Blood Protein, Glycosylated Blood Proteins, Glycated Blood Proteins, Glycosylated Blood Proteins, Glycosylated Serum Serum Protein, Glycated Serum Protein, Glycosylated Serum Proteins, Glycated Serum Proteins, Glycosylated |
||||||
| Tree number(s): |
D09.400.205.625.500 D09.400.430.825.500 D12.776.124.335 D12.776.395.351.500 D23.946.381.625.500 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000093422 | ||||||
| Scope note: | Proteins in serum that have undergone, in vivo, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Public MeSH Note: | 2023; GLYCOSYLATED SERUM PROTEIN now GLYCATED SERUM PROTEINS was indexed under BLOOD PROTEINS and GLYCOPROTEINS 1981-2022 |
||||||
| History Note: | 2023 |
||||||
| DeCS ID: | 60177 | ||||||
| Unique ID: | D000093422 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2023/01/01 | ||||||
| Date of Entry: | 2022/07/08 | ||||||
| Revision Date: | 2022/04/06 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Glycated Serum Proteins
- Preferred
Glycated Blood Proteins
- Broader
| Concept UI |
M000754074 |
| Scope note | Proteins in serum that have undergone, in vivo, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA. |
| Preferred term | Glycated Serum Proteins |
| Entry term(s) |
Glycated Serum Protein Glycosylated Serum Protein Glycosylated Serum Proteins Proteins, Glycosylated Serum Serum Protein, Glycated Serum Protein, Glycosylated Serum Proteins, Glycated Serum Proteins, Glycosylated |
| Concept UI |
M000754075 |
| Preferred term | Glycated Blood Proteins |
| Entry term(s) |
Blood Protein, Glycated Blood Protein, Glycosylated Blood Proteins, Glycated Blood Proteins, Glycosylated Glycated Blood Protein Glycosylated Blood Protein Glycosylated Blood Proteins Protein, Glycated Blood Protein, Glycosylated Blood Proteins, Glycated Blood Proteins, Glycosylated Blood |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
